Menu Content
Go Top


S. Korea Approves Janssen's Single Dose COVID-19 Vaccine

Write: 2021-04-07 16:03:10Update: 2021-04-07 16:51:44

S. Korea Approves Janssen's Single Dose COVID-19 Vaccine

Photo : YONHAP News

South Korea has approved the single-dose COVID-19 vaccine manufactured by Johnson & Johnson's pharmaceutical arm Janssen. 

The Food and Drug Safety Ministry on Wednesday held a final expert meeting and granted the authorization, making Janssen’s the third vaccine to receive approval after those by AstraZeneca and Pfizer.

However, the drug firm still needs to submit a final report on clinical test results to the Seoul government. 

Janssen Korea applied for a permit in late February. The vaccine is known to have 66 percent efficacy in adults 18 and older. The ministry said the vaccine is safe but will continue to monitor for adverse reactions.

South Korea signed a deal with Janssen to purchase six million doses, with the vaccines set to arrive in the third quarter.

Related News

Editor's Pick


This website uses cookies and other technology to enhance quality of service. Continuous usage of the website will be considered as giving consent to the application of such technology and the policy of KBS. For further details >